H syndrome

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| H syndrome | |
|---|---|
| Synonyms | Histiocytosis-lymphadenopathy plus syndrome |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Hyperpigmentation, hypertrichosis, hepatosplenomegaly, hearing loss, heart anomalies, hypogonadism, short stature, insulin-dependent diabetes mellitus |
| Complications | N/A |
| Onset | Childhood |
| Duration | Lifelong |
| Types | N/A |
| Causes | Mutations in the SLC29A3 gene |
| Risks | Family history of the condition |
| Diagnosis | Genetic testing, clinical evaluation |
| Differential diagnosis | Langerhans cell histiocytosis, Rosai-Dorfman disease, Faisalabad histiocytosis |
| Prevention | N/A |
| Treatment | Symptomatic management |
| Medication | N/A |
| Prognosis | Variable, depending on the severity of symptoms |
| Frequency | Rare |
| Deaths | N/A |
H syndrome is a rare, autosomal recessive genetic disorder characterized by a constellation of clinical features. The syndrome was first described in the medical literature in 2008, and it is caused by mutations in the SLC29A3 gene, which encodes the human equilibrative nucleoside transporter 3 (hENT3). This transporter is involved in the uptake of nucleosides, which are important for DNA repair and replication, from the extracellular space into cells. The exact mechanism by which mutations in the SLC29A3 gene lead to the diverse symptoms of H syndrome is not fully understood, but it is thought to involve disturbances in nucleoside metabolism and signaling pathways.
Symptoms[edit]
H syndrome presents with a wide range of clinical manifestations, which can vary significantly among affected individuals. Common symptoms include:
- Hyperpigmentation and hypertrichosis, particularly on the inner thighs and other areas of the body.
- Hepatomegaly (enlarged liver) or hepatosplenomegaly (enlarged liver and spleen).
- Sensorineural hearing loss.
- Short stature.
- Insulin-dependent diabetes mellitus.
- Lymphadenopathy (swelling of the lymph nodes).
- Cardiomyopathy (disease of the heart muscle).
- Skeletal abnormalities, such as joint contractures and hallux valgus (deformity of the big toe).
Diagnosis[edit]
Diagnosis of H syndrome is based on the clinical presentation and confirmed by genetic testing showing mutations in the SLC29A3 gene. Due to the rarity of the condition and the diversity of its symptoms, H syndrome can be difficult to diagnose. A multidisciplinary approach involving pediatricians, endocrinologists, dermatologists, and geneticists is often necessary to accurately diagnose and manage the condition.
Treatment[edit]
There is no cure for H syndrome, and treatment is symptomatic and supportive. Management strategies may include:
- Control of diabetes with insulin and dietary modifications.
- Hearing aids for sensorineural hearing loss.
- Physical therapy to manage joint contractures and improve mobility.
- Regular monitoring and treatment for cardiac and liver involvement.
Epidemiology[edit]
H syndrome is extremely rare, with only a few dozen cases reported in the medical literature worldwide. It affects males and females equally and has been described in individuals of various ethnic backgrounds.
Research Directions[edit]
Research on H syndrome is focused on understanding the precise role of the SLC29A3 gene in the disease, developing targeted therapies, and improving diagnostic methods. Gene therapy and other advanced treatments may offer hope for affected individuals in the future.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian